CV

Chad A. VanHuis

LY Lycera: 5 patents #1 of 26Top 4%
Merck: 3 patents #159 of 1,208Top 15%
Overall (2017): #32,465 of 506,227Top 7%
5
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9815791 Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Donald J. Skalitzky 2017-11-14
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more 2017-10-10
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more 2017-05-30
9580388 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Gary D. Glick, Alexander R. Hurd, Clarke B. Taylor 2017-02-28